In 2023, the mortality rate for female neoplasms in Sweden stood at 218.5 deaths per hundred thousand women. The forecast for the coming years shows a consistent, albeit slight, downward trend in mortality rates. From 2024 to 2028, the mortality rate is projected to decline from 218.0 to 214.7 deaths per hundred thousand women. This represents year-on-year percentage decreases, indicating a positive trend in combating neoplasms among women in Sweden.
Key variations:
- 2024 to 2025: -0.37%
- 2025 to 2026: -0.41%
- 2026 to 2027: -0.37%
- 2027 to 2028: -0.37%
Compound Annual Growth Rate (CAGR) over the forecast period (2024-2028) indicates an average annual decrease of approximately 0.39%.
Future trends to watch for include advancements in early detection technologies, improvements in medical treatments, and public health initiatives focusing on prevention and lifestyle changes. These factors will likely contribute to the ongoing decline in female neoplasm mortality rates in Sweden.
